Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04240626 · ClinicalTrials.gov registry record · Phase 4
Multimodal Analgesia Effect on Post Surgical Patient
A Phase 4 study of Surgery and Bariatric Surgery Candidate, sponsored by University of California, Davis.
- Active
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT04240626: Active Phase 4 study of Surgery and Bariatric Surgery Candidate, sponsored by University of California, Davis.
NCT04240626 is a Phase 4 study of Surgery and Bariatric Surgery Candidate that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 60 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04240626, a Phase 4 study of Surgery and Bariatric Surgery Candidate, is active but no longer recruiting, sponsored by University of California, Davis.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients undergoing Bariatric Surgery at the University of California Davis Medical Center will be divided into two groups, one receiving Standard of Care pain control medications vs the second group which will receive non-narcotic pain medications with rescue pain medications available if needed
Primary Outcome
Using the Wong-Baker Pain Rating Scale-0=No Pain, 2-4, Slight Pain, 6-8, Moderate Pain, 9-10, Severe Pain
Conditions Studied
Interventions
- DRUG Neurontin
- DRUG Dilaudid Injectable Product
- DRUG Marcaine Injectable Product
- DRUG Oxycodone Hydrochloride
- DRUG Hycet 7.5Mg-325Mg/15Ml Solution
Study Locations (1)
California
- UC Davis Health - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-01-20 |
| Est. Completion | 2026-06-24 |
| Phase | Phase 4 |
What the registry record for NCT04240626 still lists
NCT04240626 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Surgery appearing as the primary indexed condition, and to 5 interventions - of which Neurontin is the first listed.
NCT04240626 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04240626 about?
NCT04240626 is a clinical study titled "Multimodal Analgesia Effect on Post Surgical Patient". Patients undergoing Bariatric Surgery at the University of California Davis Medical Center will be divided into two groups, one receiving Standard of Care pain control medications vs the second group which will receive non-narcotic pain medications with rescue pain medications available if needed
What is the current status of trial NCT04240626?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2021-01-20. Estimated completion is 2026-06-24.
What conditions does trial NCT04240626 study?
This clinical trial studies the following conditions: Surgery, Bariatric Surgery Candidate, Obesity, Morbid.
What interventions are being tested in trial NCT04240626?
The interventions under investigation include: Neurontin (DRUG), Dilaudid Injectable Product (DRUG), Marcaine Injectable Product (DRUG), Oxycodone Hydrochloride (DRUG), Hycet 7.5Mg-325Mg/15Ml Solution (DRUG).
Who is sponsoring clinical trial NCT04240626?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04240626 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04240626's enrollment target sits among peer trials
60 81st of 120 higher than 36 of 120 other Surgery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
Continuous Versus Single Injection Adductor Canal Blocks for Outpatient Total Knee Arthroplasty
RECRUITING · Phase 4
-
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
RECRUITING · Phase 4
-
Transversus Abdominis Plane Block Compared to Local Anesthetic Wound Infiltration in Gynecologic Oncology Surgery
RECRUITING · Phase 4
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial
RECRUITING · Phase 4
-
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI